Ev3’s Atherectomy Business On The Upswing After Troubled First Quarter

Endovascular device firm ev3's formerly rocky marriage with FoxHollow is now on steadier ground with a better-than-expected recovery of its atherectomy business in the second quarter

More from Archive

More from Medtech Insight